Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C20H22O6 |
| Molecular Weight | 358.3851 |
| Optical Activity | ( - ) |
| Defined Stereocenters | 2 / 2 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
COC1=C(O)C=CC(C[C@H]2COC(=O)[C@@H]2CC3=CC(OC)=C(O)C=C3)=C1
InChI
InChIKey=MATGKVZWFZHCLI-LSDHHAIUSA-N
InChI=1S/C20H22O6/c1-24-18-9-12(3-5-16(18)21)7-14-11-26-20(23)15(14)8-13-4-6-17(22)19(10-13)25-2/h3-6,9-10,14-15,21-22H,7-8,11H2,1-2H3/t14-,15+/m0/s1
| Molecular Formula | C20H22O6 |
| Molecular Weight | 358.3851 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 2 / 2 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: GO:0006954 Sources: https://www.ncbi.nlm.nih.gov/pubmed/28512713 |
|||
Target ID: GO:0072593 Sources: https://www.ncbi.nlm.nih.gov/pubmed/22483751 |
|||
Target ID: Casein kinase I, rat Sources: https://www.ncbi.nlm.nih.gov/pubmed/12612451 |
10.0 µM [IC50] | ||
Target ID: GO:0006809 Sources: https://www.ncbi.nlm.nih.gov/pubmed/27774796 |
11.5 µM [IC50] | ||
Target ID: IL-6/STAT3 pathway Sources: https://www.ncbi.nlm.nih.gov/pubmed/25100250 |
2.92 µM [IC50] |
PubMed
| Title | Date | PubMed |
|---|---|---|
| Matairesinol Suppresses Neuroinflammation and Migration Associated with Src and ERK1/2-NF-κB Pathway in Activating BV2 Microglia. | 2017-10 |
|
| Forsythia suspensa fruit extracts and the constituent matairesinol confer anti-allergic effects in an allergic dermatitis mouse model. | 2016-07-01 |
|
| Anti-osteoclastogenic activity of matairesinol via suppression of p38/ERK-NFATc1 signaling axis. | 2014-01-21 |
|
| Matairesinol inhibits angiogenesis via suppression of mitochondrial reactive oxygen species. | 2012-04-27 |
|
| Characterization of (-)-matairesinol as a potent inhibitor of casein kinase I in vitro. | 2003-03 |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 22:53:04 GMT 2025
by
admin
on
Mon Mar 31 22:53:04 GMT 2025
|
| Record UNII |
XLW63P8WUA
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C63638
Created by
admin on Mon Mar 31 22:53:04 GMT 2025 , Edited by admin on Mon Mar 31 22:53:04 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
DB04200
Created by
admin on Mon Mar 31 22:53:04 GMT 2025 , Edited by admin on Mon Mar 31 22:53:04 GMT 2025
|
PRIMARY | |||
|
2183
Created by
admin on Mon Mar 31 22:53:04 GMT 2025 , Edited by admin on Mon Mar 31 22:53:04 GMT 2025
|
PRIMARY | |||
|
6698
Created by
admin on Mon Mar 31 22:53:04 GMT 2025 , Edited by admin on Mon Mar 31 22:53:04 GMT 2025
|
PRIMARY | |||
|
Matairesinol
Created by
admin on Mon Mar 31 22:53:04 GMT 2025 , Edited by admin on Mon Mar 31 22:53:04 GMT 2025
|
PRIMARY | |||
|
DTXSID40920490
Created by
admin on Mon Mar 31 22:53:04 GMT 2025 , Edited by admin on Mon Mar 31 22:53:04 GMT 2025
|
PRIMARY | |||
|
XLW63P8WUA
Created by
admin on Mon Mar 31 22:53:04 GMT 2025 , Edited by admin on Mon Mar 31 22:53:04 GMT 2025
|
PRIMARY | |||
|
C68496
Created by
admin on Mon Mar 31 22:53:04 GMT 2025 , Edited by admin on Mon Mar 31 22:53:04 GMT 2025
|
PRIMARY | |||
|
119205
Created by
admin on Mon Mar 31 22:53:04 GMT 2025 , Edited by admin on Mon Mar 31 22:53:04 GMT 2025
|
PRIMARY | |||
|
580-72-3
Created by
admin on Mon Mar 31 22:53:04 GMT 2025 , Edited by admin on Mon Mar 31 22:53:04 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
TARGET -> AGONIST |
|
||
|
|
PARENT -> CONSTITUENT ALWAYS PRESENT |
|
||
|
PARENT -> CONSTITUENT ALWAYS PRESENT |
21 Cell growth rate (%) of M1 cells at 50 uM of compound vs control
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
|